Management of disability in lymphatic filariasis--an update.
Identifieur interne : 009414 ( Main/Exploration ); précédent : 009413; suivant : 009415Management of disability in lymphatic filariasis--an update.
Auteurs : R K ShenoySource :
- The Journal of communicable diseases [ 0019-5138 ] ; 2002.
Descripteurs français
- KwdFr :
- Adulte, Animaux, Antihelminthiques (usage thérapeutique), Enfant, Enfant d'âge préscolaire, Filariose lymphatique (), Filariose lymphatique (traitement médicamenteux), Humains, Lymphangite (), Lymphangite (physiopathologie), Lymphangite (traitement médicamenteux), Lymphoedème (), Lymphoedème (physiopathologie), Lymphoedème (traitement médicamenteux), Personnes handicapées, Prise en charge de la maladie, Wuchereria bancrofti (pathogénicité).
- MESH :
- pathogénicité : Wuchereria bancrofti.
- physiopathologie : Lymphangite, Lymphoedème.
- traitement médicamenteux : Filariose lymphatique, Lymphangite, Lymphoedème.
- usage thérapeutique : Antihelminthiques.
- Adulte, Animaux, Enfant, Enfant d'âge préscolaire, Filariose lymphatique, Humains, Lymphangite, Lymphoedème, Personnes handicapées, Prise en charge de la maladie.
English descriptors
- KwdEn :
- Adult, Animals, Anthelmintics (therapeutic use), Child, Child, Preschool, Disabled Persons, Disease Management, Elephantiasis, Filarial (complications), Elephantiasis, Filarial (drug therapy), Humans, Lymphangitis (drug therapy), Lymphangitis (physiopathology), Lymphangitis (prevention & control), Lymphedema (drug therapy), Lymphedema (physiopathology), Lymphedema (prevention & control), Wuchereria bancrofti (pathogenicity).
- MESH :
- chemical , therapeutic use : Anthelmintics.
- complications : Elephantiasis, Filarial.
- drug therapy : Elephantiasis, Filarial, Lymphangitis, Lymphedema.
- pathogenicity : Wuchereria bancrofti.
- physiopathology : Lymphangitis, Lymphedema.
- prevention & control : Lymphangitis, Lymphedema.
- Adult, Animals, Child, Child, Preschool, Disabled Persons, Disease Management, Humans.
Abstract
The global lymphatic filariasis elimination programme incorporates disability management along with transmission control, to ensure 'a visible impact' on those who are already affected by the disease. The common manifestations of lymphatic filariasis like lymphoedema; elephantiasis and hydrocele result from irreversible damage caused to the lymphatics by the adult worms. Only palliative treatment in the form of physical methods and surgery is available for lymphoedema and elephantiasis. Hydrocele can be corrected by surgery. The most distressing aspect of lymphatic filariasis is the attacks of acute adenolymphangitis, which cause considerable short-term and also long-term disability by worsening the lymphoedema. Since each episode prevents the person from attending his work for several days, the economic loss is substantial. The precipitating cause of these attacks is secondary infection, the bacteria entering the tissues through 'entry lesions' in the skin. These episodes can very well be prevented by proper 'local-hygiene' of the affected limbs, which is a simple, effective, cheap and sustainable method that can be carried out even in the patient's house. These subjects and the providers of 'home care' should be trained in foot-hygiene programme, so that the message percolates to various levels in the affected communities, ultimately benefiting the patient.
PubMed: 12718336
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 004271
- to stream PubMed, to step Curation: 004271
- to stream PubMed, to step Checkpoint: 004271
- to stream Ncbi, to step Merge: 000D43
- to stream Ncbi, to step Curation: 000D43
- to stream Ncbi, to step Checkpoint: 000D43
- to stream Main, to step Merge: 009763
- to stream Main, to step Curation: 009414
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Management of disability in lymphatic filariasis--an update.</title><author><name sortKey="Shenoy, R K" sort="Shenoy, R K" uniqKey="Shenoy R" first="R K" last="Shenoy">R K Shenoy</name><affiliation><nlm:affiliation>Dept. of Medicine, T.D. Medical College and Hospital, Alappuzha-688 011, Kerala.</nlm:affiliation><wicri:noCountry code="subField">Kerala</wicri:noCountry></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2002">2002</date><idno type="RBID">pubmed:12718336</idno><idno type="pmid">12718336</idno><idno type="wicri:Area/PubMed/Corpus">004271</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">004271</idno><idno type="wicri:Area/PubMed/Curation">004271</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">004271</idno><idno type="wicri:Area/PubMed/Checkpoint">004271</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">004271</idno><idno type="wicri:Area/Ncbi/Merge">000D43</idno><idno type="wicri:Area/Ncbi/Curation">000D43</idno><idno type="wicri:Area/Ncbi/Checkpoint">000D43</idno><idno type="wicri:doubleKey">0019-5138:2002:Shenoy R:management:of:disability</idno><idno type="wicri:Area/Main/Merge">009763</idno><idno type="wicri:Area/Main/Curation">009414</idno><idno type="wicri:Area/Main/Exploration">009414</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Management of disability in lymphatic filariasis--an update.</title><author><name sortKey="Shenoy, R K" sort="Shenoy, R K" uniqKey="Shenoy R" first="R K" last="Shenoy">R K Shenoy</name><affiliation><nlm:affiliation>Dept. of Medicine, T.D. Medical College and Hospital, Alappuzha-688 011, Kerala.</nlm:affiliation><wicri:noCountry code="subField">Kerala</wicri:noCountry></affiliation></author></analytic><series><title level="j">The Journal of communicable diseases</title><idno type="ISSN">0019-5138</idno><imprint><date when="2002" type="published">2002</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Animals</term><term>Anthelmintics (therapeutic use)</term><term>Child</term><term>Child, Preschool</term><term>Disabled Persons</term><term>Disease Management</term><term>Elephantiasis, Filarial (complications)</term><term>Elephantiasis, Filarial (drug therapy)</term><term>Humans</term><term>Lymphangitis (drug therapy)</term><term>Lymphangitis (physiopathology)</term><term>Lymphangitis (prevention & control)</term><term>Lymphedema (drug therapy)</term><term>Lymphedema (physiopathology)</term><term>Lymphedema (prevention & control)</term><term>Wuchereria bancrofti (pathogenicity)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term><term>Animaux</term><term>Antihelminthiques (usage thérapeutique)</term><term>Enfant</term><term>Enfant d'âge préscolaire</term><term>Filariose lymphatique ()</term><term>Filariose lymphatique (traitement médicamenteux)</term><term>Humains</term><term>Lymphangite ()</term><term>Lymphangite (physiopathologie)</term><term>Lymphangite (traitement médicamenteux)</term><term>Lymphoedème ()</term><term>Lymphoedème (physiopathologie)</term><term>Lymphoedème (traitement médicamenteux)</term><term>Personnes handicapées</term><term>Prise en charge de la maladie</term><term>Wuchereria bancrofti (pathogénicité)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Anthelmintics</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Elephantiasis, Filarial</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Elephantiasis, Filarial</term><term>Lymphangitis</term><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="pathogenicity" xml:lang="en"><term>Wuchereria bancrofti</term></keywords><keywords scheme="MESH" qualifier="pathogénicité" xml:lang="fr"><term>Wuchereria bancrofti</term></keywords><keywords scheme="MESH" qualifier="physiopathologie" xml:lang="fr"><term>Lymphangite</term><term>Lymphoedème</term></keywords><keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Lymphangitis</term><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Lymphangitis</term><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Filariose lymphatique</term><term>Lymphangite</term><term>Lymphoedème</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antihelminthiques</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Animals</term><term>Child</term><term>Child, Preschool</term><term>Disabled Persons</term><term>Disease Management</term><term>Humans</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Animaux</term><term>Enfant</term><term>Enfant d'âge préscolaire</term><term>Filariose lymphatique</term><term>Humains</term><term>Lymphangite</term><term>Lymphoedème</term><term>Personnes handicapées</term><term>Prise en charge de la maladie</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The global lymphatic filariasis elimination programme incorporates disability management along with transmission control, to ensure 'a visible impact' on those who are already affected by the disease. The common manifestations of lymphatic filariasis like lymphoedema; elephantiasis and hydrocele result from irreversible damage caused to the lymphatics by the adult worms. Only palliative treatment in the form of physical methods and surgery is available for lymphoedema and elephantiasis. Hydrocele can be corrected by surgery. The most distressing aspect of lymphatic filariasis is the attacks of acute adenolymphangitis, which cause considerable short-term and also long-term disability by worsening the lymphoedema. Since each episode prevents the person from attending his work for several days, the economic loss is substantial. The precipitating cause of these attacks is secondary infection, the bacteria entering the tissues through 'entry lesions' in the skin. These episodes can very well be prevented by proper 'local-hygiene' of the affected limbs, which is a simple, effective, cheap and sustainable method that can be carried out even in the patient's house. These subjects and the providers of 'home care' should be trained in foot-hygiene programme, so that the message percolates to various levels in the affected communities, ultimately benefiting the patient.</div></front></TEI><affiliations><list></list><tree><noCountry><name sortKey="Shenoy, R K" sort="Shenoy, R K" uniqKey="Shenoy R" first="R K" last="Shenoy">R K Shenoy</name></noCountry></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 009414 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 009414 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:12718336
|texte= Management of disability in lymphatic filariasis--an update.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:12718336" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |